P
BiomX D
D
PHGE
0.76290
USD
-0.05
(-6.04%)
مغلق
حجم التداول
696
الربح لكل سهم
0
العائد الربحي
0
P/E
-0
حجم السوق
13,652,739
المقالات
العنوان: BiomX Inc
القطاع: Healthcare
الصناعة: Biotechnology
BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.